These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Phenylbutazone in nonarticular rheumatism. MCCORMICK EW GP; 1956 Sep; 14(3):95-7. PubMed ID: 13356958 [No Abstract] [Full Text] [Related]
26. Deglycyrrhizinized liquorice in the treatment of chronic duodenal ulcer. A retrospective endoscopic survey of 32 patients. Larkworthy W; Holgate PF Practitioner; 1975 Dec; 215(1290):787-92. PubMed ID: 772652 [TBL] [Abstract][Full Text] [Related]
27. [Thirty cases of rheumatic disease cured with phenylbutazone]. QUARTI ML Minerva Pediatr; 1956 Jul; 8(29-30):934-5. PubMed ID: 13369321 [No Abstract] [Full Text] [Related]
28. [Phenylbutazone in therapy of rheumatic diseases and bronchial asthma]. LUCHERINI T; CONESTABILE E; NATALE P; GOSPODINOFF A Minerva Med; 1953 May; 44(37):1213-29. PubMed ID: 13072024 [No Abstract] [Full Text] [Related]
29. The status of G-27202 (metabolite 1 of phenylbutazone) in the treatment of rheumatic disorders. GRAHAM W Can Med Assoc J; 1960 May; 82(20):1005-8. PubMed ID: 13828827 [No Abstract] [Full Text] [Related]
30. The status of phenylbutazone (butazolidin) in the treatment of rheumatic disorders. GRAHAM W Can Med Assoc J; 1958 Oct; 79(8):634-8. PubMed ID: 13585285 [No Abstract] [Full Text] [Related]
31. Phenylbutazone therapy in patients with rheumatic disease and coincidental essential hypertension. ZUCKNER J; AHERN AM; MACHEK O; CACIOLO C Am J Med Sci; 1958 Oct; 236(4):460-5. PubMed ID: 13582939 [No Abstract] [Full Text] [Related]
32. [Therapeutic experiences with the antirheumatic agent delta-butazolidine at the rheumatology center of Koeflach]. REISENHOFER A Wien Med Wochenschr; 1961 Apr; 111():245-7. PubMed ID: 13740654 [No Abstract] [Full Text] [Related]
33. [Use of liquid extract of liquorice for pulmonary tuberculosis]. HUANG KH; WAN CC Shandong Yi Kan; 1959 Jun; 21():17-8. PubMed ID: 14449574 [No Abstract] [Full Text] [Related]
34. [Research on the mechanism of action of phenylbutazone in rheumatic diseases]. PAUNESCU-PODEANU A; DINU I; GEORGESCU I; STERESCU P Probl Reumatol; 1959; 6():57-64. PubMed ID: 24546198 [No Abstract] [Full Text] [Related]
35. PRESENT status of phenylbutazone therapy (butazolidin). J Med Assoc Ga; 1953 Jun; 42(6):268-9. PubMed ID: 13069925 [No Abstract] [Full Text] [Related]
37. [The use of phenylbutazone in some cases of chronic rheumatism among the Bantu]. MAIRLOT F Rev Med Liege; 1958 Feb; 13(4):107-12. PubMed ID: 13528292 [No Abstract] [Full Text] [Related]
38. [Considerations on the clinical use of a new preparation with a pyrazolone-pyrazolidine base in rheumatological and traumatological fields]. PADOVANI PU Minerva Med; 1960 Oct; 51():3559-64. PubMed ID: 13731983 [No Abstract] [Full Text] [Related]
39. [Results obtained with the use of calcium phenylbutazone combined with prednisone in rheumatic diseases]. NEBO F; SPILBORGHS G Rev Assoc Med Bras; 1959; 5():164-9. PubMed ID: 14426287 [No Abstract] [Full Text] [Related]
40. Phenylbutazone therapy; relation between the toxic and therapeutic effects and the blood level. BRUCK E; FEARNLEY ME; MEANOCK I; PATLEY H Lancet; 1954 Jan; 266(6805):225-8. PubMed ID: 13131825 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]